Cefotiam hexetil is a prodrug of cefotiam. The concentrations of cefotiam in plasma and sinus secretions were determined in 18 patients (10 males, 8 females, aged 39.3 +/- 13.0 years) with chronic sinusitis. All patients received two 200 mg oral doses of cefotiam hexetil 12 h apart and were divided into four groups according to the time which elapsed between the last dose and collection of secretion samples. The last dose was given 2 h (group I), 3 h (group II), 4 h (group III) or 6 h (group IV) before sinus puncture. Cefotiam concentrations were measured by high-pressure liquid chromatography and microbiological assay, results being very similar with both methods. Mean concentrations of cefotiam with the standard deviation in sinus exudates were 1.04 +/- 0.60 mg/l at 2 h (n = 6), 1.04 +/- 0.33 mg/l at 3 h (n = 4), 0.75 +/- 0.74 mg/l at 4 h (n = 4) and < 0.10 mg/l at 6 h (n = 4). Mean sinus fluid concentrations were higher than mean plasma concentrations in all groups. These results suggest that cefotiam concentrations higher than the MICs for common pathogens are found in sinus secretions up to 4 h after oral administration of cefotiam hexetil.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF01967115 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Experience with Off-Label Intrathecal Administration of Selected Antibiotics in Adults: An Overview with Pharmacometric Considerations.
Antibiotics (Basel)
August 2023
Center for Antimicrobial Treatment Optimization Rotterdam (CATOR), 3015 GD Rotterdam, The Netherlands.
Article Synopsis
- - Drain-associated intracerebral infections are serious medical emergencies that are hard to treat because antibiotics struggle to reach the infection site, especially with the rise of multidrug-resistant bacteria, leading to potential use of off-label intrathecal (IT) antibiotics.
- - The study reviewed existing literature on IT dosing regimens and summarized clinical experiences with various antibiotics, showing how factors like the size of the ventricular system and CSF drainage volume influence treatment effectiveness.
- - While many side effects were noted for benzylpenicillin in earlier years, other antibiotics had mostly minor and reversible side effects when used properly, providing insight for choosing IT dosing strategies in cases of antibiotic resistance.
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2: A Combined in silico and in vitro Study.
Mol Inform
February 2022
Department of Medical Biology, School of Medicine, Bahcesehir University, 34734, Istanbul, Turkey.
In the current study, we used 7922 FDA approved small molecule drugs as well as compounds in clinical investigation from NIH's NPC database in our drug repurposing study. SARS-CoV-2 main protease as well as Spike protein/ACE2 targets were used in virtual screening and top-100 compounds from each docking simulations were considered initially in short molecular dynamics (MD) simulations and their average binding energies were calculated by MM/GBSA method. Promising hit compounds selected based on average MM/GBSA scores were then used in long MD simulations.
View Article and Find Full Text PDFThe pharmacokinetics of antibiotics in cystic fibrosis.
Expert Opin Drug Metab Toxicol
January 2021
Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Introduction: Dosing of antibiotics in people with cystic fibrosis (CF) is challenging, due to altered pharmacokinetics, difficulty of lung tissue penetration, and increasing presence of antimicrobial resistance.
Areas Covered: The purpose of this work is to critically review original data as well as previous reviews and guidelines on pharmacokinetics of systemic and inhaled antibiotics in CF, with the aim to propose strategies for optimization of antibacterial therapy in both children and adults with CF.
Expert Opinion: For systemic antibiotics, absorption is comparable in CF patients and non-CF controls.
Cefotiam Treatment in Children: Evidence of Subtherapeutic Levels.
Ther Drug Monit
October 2020
Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
Background: Cefotiam, a second-generation cephalosporin, is a broad-spectrum antibiotic with good antibacterial action against both gram-negative and gram-positive bacteria. It is used widely in clinical practice, although bacterial drug resistance makes its clinical use problematic. The authors hypothesized that subtherapeutic concentrations of cefotiam leads to bacterial resistance.
View Article and Find Full Text PDFEfficacy of Antibiotic-Loaded Hydroxyapatite/Collagen Composites Is Dependent on Adsorbability for Treating Staphylococcus aureus Osteomyelitis in Rats.
J Orthop Res
April 2020
Department of Orthopaedic Research and Development, Graduate School, Tokyo, Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
Osteomyelitis remains one of the most challenging disorders for orthopedic doctors despite the advancement of therapeutic techniques. The purpose of this study was to investigate the feasibility of local antibiotic administration using hydroxyapatite/collagen (HAp/Col) as a drug delivery system. We hypothesized that higher adsorbability of antibiotics onto HAp/Col will result in more efficacious activity and therefore, treatment of osteomyelitis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!